Global Prenatal Testing and Newborn Screening Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Prenatal testing is performed on the mother during pregnancy. Newborn screening is performed after the baby is born.

    Prenatal Testing and Newborn Screening market report explains the definition, types, applications, major countries, and major players of the Prenatal Testing and Newborn Screening market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Agilent Technologies

    • Qiagen NV

    • Editas Medicine

    • Eurofins Scientific

    • Abbott Laboratories

    • Illumina Inc

    • Bio-Rad Laboratories

    • Color Genomics

    • Edinburgh Genomics

    • CRISPR

    By Type:

    • Prenatal Testing

    • Newborn Screening

    By End-User:

    • Hospitals

    • Pathology Labs

    • Gynecology Clinics

    • Research Organizations

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Prenatal Testing and Newborn Screening Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Prenatal Testing and Newborn Screening Outlook to 2028- Original Forecasts

    • 2.2 Prenatal Testing and Newborn Screening Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Prenatal Testing and Newborn Screening Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Prenatal Testing and Newborn Screening Market- Recent Developments

    • 6.1 Prenatal Testing and Newborn Screening Market News and Developments

    • 6.2 Prenatal Testing and Newborn Screening Market Deals Landscape

    7 Prenatal Testing and Newborn Screening Raw Materials and Cost Structure Analysis

    • 7.1 Prenatal Testing and Newborn Screening Key Raw Materials

    • 7.2 Prenatal Testing and Newborn Screening Price Trend of Key Raw Materials

    • 7.3 Prenatal Testing and Newborn Screening Key Suppliers of Raw Materials

    • 7.4 Prenatal Testing and Newborn Screening Market Concentration Rate of Raw Materials

    • 7.5 Prenatal Testing and Newborn Screening Cost Structure Analysis

      • 7.5.1 Prenatal Testing and Newborn Screening Raw Materials Analysis

      • 7.5.2 Prenatal Testing and Newborn Screening Labor Cost Analysis

      • 7.5.3 Prenatal Testing and Newborn Screening Manufacturing Expenses Analysis

    8 Global Prenatal Testing and Newborn Screening Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Prenatal Testing and Newborn Screening Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Prenatal Testing and Newborn Screening Export by Region (Top 10 Countries) (2017-2028)

    9 Global Prenatal Testing and Newborn Screening Market Outlook by Types and Applications to 2022

    • 9.1 Global Prenatal Testing and Newborn Screening Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prenatal Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Newborn Screening Consumption and Growth Rate (2017-2022)

    • 9.2 Global Prenatal Testing and Newborn Screening Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pathology Labs Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gynecology Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Research Organizations Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Prenatal Testing and Newborn Screening Market Analysis and Outlook till 2022

    • 10.1 Global Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.2.2 Canada Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.2.3 Mexico Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.2 UK Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.3 Spain Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.4 Belgium Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.5 France Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.6 Italy Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.7 Denmark Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.8 Finland Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.9 Norway Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.10 Sweden Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.11 Poland Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.12 Russia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.3.13 Turkey Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.2 Japan Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.3 India Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.4 South Korea Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.5 Pakistan Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.6 Bangladesh Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.7 Indonesia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.8 Thailand Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.9 Singapore Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.10 Malaysia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.11 Philippines Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.4.12 Vietnam Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.2 Colombia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.3 Chile Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.4 Argentina Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.5 Venezuela Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.6 Peru Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.7 Puerto Rico Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.5.8 Ecuador Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.6.2 Kuwait Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.6.3 Oman Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.6.4 Qatar Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.7.2 South Africa Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.7.3 Egypt Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.7.4 Algeria Prenatal Testing and Newborn Screening Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Prenatal Testing and Newborn Screening Consumption (2017-2022)

      • 10.8.2 New Zealand Prenatal Testing and Newborn Screening Consumption (2017-2022)

    11 Global Prenatal Testing and Newborn Screening Competitive Analysis

    • 11.1 Agilent Technologies

      • 11.1.1 Agilent Technologies Company Details

      • 11.1.2 Agilent Technologies Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Agilent Technologies Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.1.4 Agilent Technologies Prenatal Testing and Newborn Screening Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Qiagen NV

      • 11.2.1 Qiagen NV Company Details

      • 11.2.2 Qiagen NV Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Qiagen NV Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.2.4 Qiagen NV Prenatal Testing and Newborn Screening Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Editas Medicine

      • 11.3.1 Editas Medicine Company Details

      • 11.3.2 Editas Medicine Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Editas Medicine Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.3.4 Editas Medicine Prenatal Testing and Newborn Screening Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Eurofins Scientific

      • 11.4.1 Eurofins Scientific Company Details

      • 11.4.2 Eurofins Scientific Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Eurofins Scientific Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.4.4 Eurofins Scientific Prenatal Testing and Newborn Screening Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Abbott Laboratories

      • 11.5.1 Abbott Laboratories Company Details

      • 11.5.2 Abbott Laboratories Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Abbott Laboratories Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.5.4 Abbott Laboratories Prenatal Testing and Newborn Screening Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Illumina Inc

      • 11.6.1 Illumina Inc Company Details

      • 11.6.2 Illumina Inc Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Illumina Inc Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.6.4 Illumina Inc Prenatal Testing and Newborn Screening Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Bio-Rad Laboratories

      • 11.7.1 Bio-Rad Laboratories Company Details

      • 11.7.2 Bio-Rad Laboratories Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Bio-Rad Laboratories Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.7.4 Bio-Rad Laboratories Prenatal Testing and Newborn Screening Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Color Genomics

      • 11.8.1 Color Genomics Company Details

      • 11.8.2 Color Genomics Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Color Genomics Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.8.4 Color Genomics Prenatal Testing and Newborn Screening Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Edinburgh Genomics

      • 11.9.1 Edinburgh Genomics Company Details

      • 11.9.2 Edinburgh Genomics Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Edinburgh Genomics Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.9.4 Edinburgh Genomics Prenatal Testing and Newborn Screening Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 CRISPR

      • 11.10.1 CRISPR Company Details

      • 11.10.2 CRISPR Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 CRISPR Prenatal Testing and Newborn Screening Main Business and Markets Served

      • 11.10.4 CRISPR Prenatal Testing and Newborn Screening Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Prenatal Testing and Newborn Screening Market Outlook by Types and Applications to 2028

    • 12.1 Global Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pathology Labs Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Gynecology Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Prenatal Testing and Newborn Screening Market Analysis and Outlook to 2028

    • 13.1 Global Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.2.2 Canada Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.2 UK Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.3 Spain Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.5 France Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.6 Italy Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.8 Finland Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.9 Norway Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.11 Poland Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.12 Russia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.2 Japan Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.3 India Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.3 Chile Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.6 Peru Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.6.3 Oman Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Prenatal Testing and Newborn Screening Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Prenatal Testing and Newborn Screening

    • Figure of Prenatal Testing and Newborn Screening Picture

    • Table Global Prenatal Testing and Newborn Screening Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Prenatal Testing and Newborn Screening Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Prenatal Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Pathology Labs Consumption and Growth Rate (2017-2022)

    • Figure Global Gynecology Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Table North America Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure United States Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Canada Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Mexico Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table Europe Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure Germany Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure UK Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Spain Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Belgium Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure France Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Italy Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Denmark Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Finland Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Norway Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Sweden Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Poland Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Russia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Turkey Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table APAC Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure China Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Japan Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure India Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure South Korea Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Thailand Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Singapore Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Philippines Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table South America Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure Brazil Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Colombia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Chile Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Argentina Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Peru Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table GCC Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure Bahrain Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Oman Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Qatar Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table Africa Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure Nigeria Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure South Africa Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Egypt Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure Algeria Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table Oceania Prenatal Testing and Newborn Screening Consumption by Country (2017-2022)

    • Figure Australia Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Prenatal Testing and Newborn Screening Consumption and Growth Rate (2017-2022)

    • Table Agilent Technologies Company Details

    • Table Agilent Technologies Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Agilent Technologies Prenatal Testing and Newborn Screening Product Portfolio

    • Table Qiagen NV Company Details

    • Table Qiagen NV Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qiagen NV Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Qiagen NV Prenatal Testing and Newborn Screening Product Portfolio

    • Table Editas Medicine Company Details

    • Table Editas Medicine Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Editas Medicine Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Editas Medicine Prenatal Testing and Newborn Screening Product Portfolio

    • Table Eurofins Scientific Company Details

    • Table Eurofins Scientific Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eurofins Scientific Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Eurofins Scientific Prenatal Testing and Newborn Screening Product Portfolio

    • Table Abbott Laboratories Company Details

    • Table Abbott Laboratories Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Abbott Laboratories Prenatal Testing and Newborn Screening Product Portfolio

    • Table Illumina Inc Company Details

    • Table Illumina Inc Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Inc Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Illumina Inc Prenatal Testing and Newborn Screening Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Bio-Rad Laboratories Prenatal Testing and Newborn Screening Product Portfolio

    • Table Color Genomics Company Details

    • Table Color Genomics Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Color Genomics Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Color Genomics Prenatal Testing and Newborn Screening Product Portfolio

    • Table Edinburgh Genomics Company Details

    • Table Edinburgh Genomics Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table Edinburgh Genomics Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table Edinburgh Genomics Prenatal Testing and Newborn Screening Product Portfolio

    • Table CRISPR Company Details

    • Table CRISPR Prenatal Testing and Newborn Screening Sales, Price, Value and Gross Profit (2017-2022)

    • Table CRISPR Prenatal Testing and Newborn Screening Main Business and Markets Served

    • Table CRISPR Prenatal Testing and Newborn Screening Product Portfolio

    • Figure Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pathology Labs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gynecology Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Table North America Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure United States Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure Germany Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure China Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure Brazil Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Prenatal Testing and Newborn Screening Consumption Forecast by Country (2022-2028)

    • Figure Australia Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Prenatal Testing and Newborn Screening Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.